What Is Pyoverdine? Definition and What Research Reports

Pyoverdine (also written pyoverdin) is a fluorescent, iron-chelating molecule — a siderophore — produced and secreted by fluorescent Pseudomonas species, including Pseudomonas aeruginosa and many plant- and soil-associated pseudomonads. Each pyoverdine consists of three parts: a conserved dihydroxyquinoline chromophore that gives the molecule its characteristic yellow-green fluorescence, a variable peptide chain of roughly six to fourteen amino acids (often including unusual or D-configured residues), and a small acyl side chain attached to the chromophore. The molecule's function in nature is to scavenge ferric iron from the environment and deliver it back to the producing bacterium through dedicated outer-membrane receptors. Because the peptide backbone is assembled enzymatically rather than on a ribosome, pyoverdine is classified among the non-ribosomal peptides, which is the main reason the term surfaces in peptide chemistry and peptide analytics literature.

What class of molecule is pyoverdine?

Pyoverdine belongs to the siderophore class: low-molecular-weight secondary metabolites that bind ferric iron with very high affinity. Within that class, it is a non-ribosomal peptide siderophore with a chromophore. A 2018 review of pyoverdine biosynthesis described the pathway as a non-ribosomal peptide synthetase (NRPS) system in which modular enzymes assemble the peptide chain and the chromophore is formed and matured through additional tailoring steps (PMID 30386787). A 2019 structural analysis examined how the pyoverdine chromophore came to have its particular architecture and how that architecture relates to iron coordination (PMID 31214860).

Because the peptide portion varies between strains while the chromophore stays largely conserved, well over a hundred distinct pyoverdines have been catalogued across Pseudomonas species. Researchers frequently describe pyoverdines as strain-specific "fingerprints," a property that underpins the analytical work summarised below.

Where pyoverdine comes from

Pyoverdine is bacterial in origin. It is not synthesised by human or animal cells, and it is not a hormone, growth factor, or receptor-targeting therapeutic peptide. The producing organisms are aerobic Gram-negative bacteria in the genus Pseudomonas; production is typically upregulated under iron limitation. A 2003 genomics review examined how the genes for pyoverdine-mediated iron uptake are organised in pseudomonads and how receptor and transport genes map onto the diversity of pyoverdine structures (PMID 12781517). Work in the environmental species Pseudomonas thivervalensis reported that iron acquisition there involved both pyoverdine and a second siderophore, histicorrugatin (PMID 27007713), illustrating that pyoverdine often operates alongside other chelators such as pyochelin.

How the term is used in peptide research

In peptide-focused literature, "pyoverdine" usually appears in one of four contexts:

• Non-ribosomal peptide biosynthesis. As a textbook example of NRPS assembly-line chemistry, including epimerisation to D-amino acids and cyclisation (PMID 30386787).
• Peptide structure elucidation. As an analytical challenge for tandem mass spectrometry, because the peptide chain must be sequenced de novo from fragment ions (PMID 35084507).
• Metal–peptide coordination chemistry. As a model for how a peptide scaffold plus a chromophore coordinates ferric iron (PMID 31214860).
• Microbial diagnostics and biotechnology. As a detectable biomarker of Pseudomonas presence and as a scaffold discussed for applied uses (PMID 36232800).

The term is not used in the literature covered here to describe a compound administered to human or animal subjects for a therapeutic purpose.

What the published literature reports

Iron uptake and bacterial physiology

The core reported function is iron scavenging. The 2003 genomics review described pyoverdine-mediated iron uptake as a receptor-dependent system encoded across pseudomonad genomes, with receptor specificity matching pyoverdine structural type (PMID 12781517). A 2015 study in Frontiers in Microbiology reported that cell aggregation promoted pyoverdine-dependent iron uptake and virulence in Pseudomonas aeruginosa, linking the siderophore system to how densely the bacteria grow together (PMID 26379660). A 2016 report characterised pyoverdine- and histicorrugatin-mediated iron acquisition in P. thivervalensis, describing two parallel chelation routes in a single organism (PMID 27007713).

Biosynthesis and structure

The 2018 Microbial Cell review synthesised the enzymology of pyoverdine assembly, covering the NRPS modules, chromophore maturation and the periplasmic and membrane steps involved in producing the mature, secreted molecule (PMID 30386787). A 2019 paper in JBIC addressed the chromophore itself, asking whether its iron-binding geometry reflected chance or selection during evolution (PMID 31214860). A 2022 review in the International Journal of Molecular Sciences covered the topic end-to-end, from biosynthesis through proposed biotechnological applications (PMID 36232800).

Measurement and analytical methods

A substantial share of the pyoverdine literature is methodological. A 2014 Methods in Molecular Biology chapter set out laboratory procedures for measuring pyoverdine and pyochelin from bacterial cultures (PMID 24818914). A 2022 paper described a comprehensive UHPLC–high-resolution MS/MS method to elucidate pyoverdines produced by fluorescent Pseudomonas spp. (PMID 35084507), and a 2023 article in Chimia extended pyoverdine analysis from high-resolution MS/MS fragmentation to ion mobility measurements (PMID 38047806). A 2024 paper in Frontiers in Chemistry reported the development of pyoverdine-binding aptamers used for label-free electrochemical detection of pseudomonads (PMID 39148668).

Diagnostic and antibacterial-target contexts

Because pyoverdine is fluorescent and specific to pseudomonads, it has been examined as a detection marker. A study published in ACS Applied Bio Materials described a pyoverdine assay intended for rapid and early detection of Pseudomonas aeruginosa in burn wounds (PMID 35021709). On the intervention side, a 2021 mSphere study reported that pyoverdine inhibitors and gallium nitrate acted synergistically against Pseudomonas aeruginosa, treating the siderophore pathway as an antibacterial target rather than as a drug itself (PMID 34133200).

Where the term shows up: a quick orientation

Human Exposure and Adverse Events: What Studies Report

The verified literature summarised on this page is microbiological, analytical and structural. It did not report human dosing studies, administration protocols, or clinical adverse-event data for pyoverdine as an administered substance. The closest clinical-adjacent work described pyoverdine as a detected analyte in the context of burn wound infection rather than as an agent given to subjects (PMID 35021709), and the antibacterial work targeted pyoverdine production rather than delivering pyoverdine (PMID 34133200). Any statement about human safety would therefore go beyond what these papers reported.

Limitations of the current literature

• Pyoverdine is a family of related molecules, not a single defined compound; findings in one strain's pyoverdine do not automatically transfer to another, which is precisely why comprehensive structure-elucidation methods were developed (PMID 35084507).
• Most mechanistic work sits at the level of bacterial culture and genomics rather than whole organisms (PMID 12781517).
• Applied proposals have been discussed largely at review level, with the 2022 review framing biotechnological application as a forward-looking area (PMID 36232800).

This page is for educational purposes only and is not medical advice; consult a licensed physician about any health or treatment question. Pyoverdine, as described in the sources above, is a bacterial metabolite studied in laboratory and analytical settings.

References

• Pyoverdine and pyochelin measurements (Methods in Molecular Biology, 2014)
• Pyoverdine Assay for Rapid and Early Detection of Pseudomonas aeruginosa in Burn Wounds (ACS Applied Bio Materials, 2020)
• Pyoverdine Analysis - From High-resolution MS/MS Fragmentation to Ion Mobility Measurements (Chimia, 2023)
• The biosynthesis of pyoverdines (Microbial Cell, 2018)
• Genomics of pyoverdine-mediated iron uptake in pseudomonads (Trends in Microbiology, 2003)
• Pyoverdine binding aptamers and label-free electrochemical detection of pseudomonads (Frontiers in Chemistry, 2024)
• A comprehensive method to elucidate pyoverdines produced by fluorescent Pseudomonas spp. by UHPLC-HR-MS/MS (Analytical and Bioanalytical Chemistry, 2022)
• Pyoverdine Inhibitors and Gallium Nitrate Synergistically Affect Pseudomonas aeruginosa (mSphere, 2021)
• Novel Insights on Pyoverdine: From Biosynthesis to Biotechnological Application (International Journal of Molecular Sciences, 2022)
• Ironing out pyoverdine's chromophore structure: serendipity or design? (JBIC, 2019)
• Cell aggregation promotes pyoverdine-dependent iron uptake and virulence in Pseudomonas aeruginosa (Frontiers in Microbiology, 2015)
• Pyoverdine and histicorrugatin-mediated iron acquisition in Pseudomonas thivervalensis (Biometals, 2016)